NCT01969565View on ClinicalTrials.gov

Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma

PHASE2TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Multiple Myeloma

Interventions

DRUG

Carfilzomib

DRUG

Dexamethasone

Trial Locations (1)

30322

Winship Cancer Institute-Emory University, Atlanta

Sponsors

Collaborators (1)

Onyx Therapeutics, Inc.

All Listed Sponsors

collaborator

Onyx Therapeutics, Inc.

INDUSTRY

lead

Emory University

OTHER

NCT01969565 - Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma | Biotech Hunter | Biotech Hunter